Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival
Authors:
- 16 January 2012
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 47 (9) , 1186-1190
Abstract
We report a single-center experience in treating 18 consecutive patients with severe aplastic anemia (SAA) who received unrelated cord blood transplantation (CBT). The median age was 17 years (range 5–61 years). Sixteen cases received a reduced-intensity regimen composed of CY (total dose1200 mg/m2), rabbit antithymocyte globulin (ATG, total dose 30 mg/kg) and fludarabine (FLU, total dose 120 mg/m2). CYA and mycophenolate mofetil were used as GVHD prophylaxis. Two patients were not evaluable for engraftment because of early death on day +21 and +22. Only one of the sixteen cases achieved engraftment, but experienced secondary graft failure 3 months post transplantation. Fifteen patients experienced primary graft rejection, but all of them acquired autologous recovery. The 3-month and 6-month cumulative incidence of response was 56% and 81%, respectively. So far, 16 patients have survived for 330–1913 days (median, 750 days) after transplantation. The probability of OS at 2 years was 88.9%. Our data indicate that CBT for newly diagnosed SAA using no irradiation but FLU and ATG-based conditioning still seems to inevitably lead to the high risk of rejection, but may facilitate autologous recovery and improve survival with low risk of transplant-related mortality.Keywords
This publication has 28 references indexed in Scilit:
- Umbilical cord blood transplantation for non-malignant diseasesBone Marrow Transplantation, 2009
- Diagnosis and Treatment of Acquired Aplastic AnemiaHematology/Oncology Clinics of North America, 2009
- Epidemiology of aplastic anemia: a prospective multicenter studyHaematologica, 2008
- Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow TransplantationHaematologica, 2007
- Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioningPediatric Transplantation, 2006
- Overcoming graft rejection in heavily transfused and allo‐immunised patients with bone marrow failure syndromes using fludarabine‐based haematopoietic cell transplantationBritish Journal of Haematology, 2006
- Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapyBone Marrow Transplantation, 2004
- Successful reduced-intensity stem cell transplantation (RIST) with mismatched cord blood in a 70-year-old patient with severe aplastic anemia (SAA)Bone Marrow Transplantation, 2003
- Successful Engraftment in Two Adult Patients with Severe Aplastic Anemia Using Nonmyeloablative Conditioning Followed by Unrelated HLA-Mismatched Cord Blood TransplantationJournal of Hematotherapy & Stem Cell Research, 2001
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989